<DOC>
	<DOCNO>NCT00695604</DOCNO>
	<brief_summary>The purpose study compare effect high-dose ICS vs. placebo adult chronic stable asthma .</brief_summary>
	<brief_title>Repeated High-dose Inhaled Corticosteroids Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criterion : Physician diagnosis asthma . Age ≥18 year ≤50 year Evidence airflow obstruction measure spirometry flowvolume loop per American Thoracic Society guideline . Treatment asthma : daily inhale corticosteroid longacting beta2agonists , AND asneeded use shortacting beta2agonist Exclusion criterion : History &gt; 10 packyear tobacco use Other pulmonary cardiac diagnosis actively treat History adverse event allergy fluticasone Systemic corticosteroid therapy within 7 day study visit Inability obtain write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Acute asthma</keyword>
	<keyword>fluticasone</keyword>
	<keyword>inhaled corticosteroid</keyword>
</DOC>